Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4872093
Max Phase: Preclinical
Molecular Formula: C28H27F3N8O2S2
Molecular Weight: 628.71
Molecule Type: Unknown
Associated Items:
ID: ALA4872093
Max Phase: Preclinical
Molecular Formula: C28H27F3N8O2S2
Molecular Weight: 628.71
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=c1c2sc(=S)n(-c3ccc(F)cc3)c2ncn1CCN1CCN(CC(O)(Cn2cncn2)c2ccc(F)cc2F)CC1
Standard InChI: InChI=1S/C28H27F3N8O2S2/c29-19-1-4-21(5-2-19)39-25-24(43-27(39)42)26(40)37(18-33-25)12-11-35-7-9-36(10-8-35)14-28(41,15-38-17-32-16-34-38)22-6-3-20(30)13-23(22)31/h1-6,13,16-18,41H,7-12,14-15H2
Standard InChI Key: VJPXCZQOUWSORV-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 628.71 | Molecular Weight (Monoisotopic): 628.1650 | AlogP: 3.19 | #Rotatable Bonds: 9 |
Polar Surface Area: 97.24 | Molecular Species: NEUTRAL | HBA: 12 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 10 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.85 | CX Basic pKa: 6.83 | CX LogP: 3.41 | CX LogD: 3.31 |
Aromatic Rings: 5 | Heavy Atoms: 43 | QED Weighted: 0.25 | Np Likeness Score: -1.46 |
1. Blokhina SV, Sharapova AV, Ol'khovich MV, Doroshenko IA, Levshin IB, Perlovich GL.. (2021) Synthesis and antifungal activity of new hybrids thiazolo[4,5-d]pyrimidines with (1H-1,2,4)triazole., 40 [PMID:33713781] [10.1016/j.bmcl.2021.127944] |
Source(1):